Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors

Acta Neuropathologica(2024)10.1007/s00401-024-02736-8Source: DataRank Database

Genome-wide loss of heterozygosity predicts aggressive, treatment-refractory behavior in pituitary neuroendocrine tumors is a research paper published in Acta Neuropathologica (2024). On theSindex it has a DataRank of 0.505. It has been cited 28 times.

N/A

0.505DataRank · unranked

Scored on demand from live citation data

Open Access28 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 7.52)OA: hybridTopics (64)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.505

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (25)

Vasilisa A. Rudneva ORCID,Allison L. Richards ORCID,Yanming Zhang ORCID,Hyung Jun Woo ORCID,Marc A. Cohen ORCID

Live enrichment

PubMed:38758238 PMC:PMC11101347 OpenAlex:https://openalex.org/W4397010954

National Institutes of Health

Grant: R21 CA280469-01

National Institutes of Health

Grant: P30 CA008748

NCI NIH HHS

Grant: R21 CA280469

National Institutes of Health

Grant: 1R21CA280469-01

Molecular biomarkers of future aggressive behavior in pituitary tumors

National Institutes of Health

Grant: 2P30CA008748-43

MOUSE GENETICS

Marie-Josée and Henry R. Kravis Center for Molecular Oncology

Cycle for Survival

FWCI

7.52

Citation Percentile

1.0%

Citation Trend

2024

2025

2026

hybridLicense: cc-by

journalhttps://link.springer.com/content/pdf/10.1007/s00401-024-02736-8.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s00401-024-02736-8.pdf

publisherhttps://link.springer.com/article/10.1007/s00401-024-02736-8/fulltext.html

journalhttps://doi.org/10.1007/s00401-024-02736-8

repositoryhttps://pubmed.ncbi.nlm.nih.gov/38758238

Fields of Study

Pituitary Gland Disorders and TreatmentsAdrenal and Paraganglionic TumorsGlioma Diagnosis and Treatment0301 basic medicine0303 health sciences03 medical and health sciencesHumansLoss of HeterozygosityPituitary NeoplasmsNeuroendocrine TumorsMaleFemaleMiddle AgedAdultAgedRetrospective StudiesMutationProspective Studies

MeSH Terms

AdultAgedFemaleHumansMaleMiddle AgedMutationPituitary NeoplasmsProspective StudiesRetrospective StudiesNeuroendocrine TumorsLoss of Heterozygosity

Keywords

Loss of heterozygosityRefractory (planetary science)Refractory periodInternal medicineCorticotropic cellAneuploidyProspective cohort studyOncologyChromosome instabilityBiologyMedicineGastroenterologyPituitary glandGeneGeneticsHormoneChromosomeAllelePituitary CarcinomaAggressive Pituitary TumorTreatment-refractory Pituitary TumorPituitary Neuroendocrine TumorMaleAdultOriginal PaperMiddle AgedNeuroendocrine TumorsMutationHumansPituitary NeoplasmsFemaleProspective StudiesAgedRetrospective Studies

Sustainable Development Goals

SDG 0: Good health and well-being